Get Live Data

Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 218.00
Bid: 215.00
Ask: 217.50
Change: 5.50 (2.59%)
Spread: 2.50 (1.163%)
Open: 219.50
High: 219.50
Low: 207.00
Prev. Close: 212.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

8 Jan 2024 07:00

RNS Number : 8606Y
PureTech Health PLC
08 January 2024
 

8 January 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

5 January 2024

Number of ordinary shares purchased:

47,027

Highest price paid per share:

202.50p

Lowest price paid per share:

200.50p

Volume weighted average price paid per share:

201.07p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,852,872 ordinary shares in treasury and has 271,615,287 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 271,615,287 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

05/01/2024

13:31:03

421

202

BATE

00384370170TRLO0.1.1

05/01/2024

13:31:03

31

202

BATE

00384370171TRLO0.1.1

05/01/2024

13:31:03

452

202

CHIX

00384370172TRLO0.1.1

05/01/2024

13:31:03

904

202

XLON

00384370173TRLO0.1.1

05/01/2024

13:31:03

249

202

TRQX

00384370174TRLO0.1.1

05/01/2024

13:31:03

420

202

AQXE

00384370175TRLO0.1.1

05/01/2024

13:41:32

236

201

XLON

00384373551TRLO0.1.1

05/01/2024

13:41:32

234

201

CHIX

00384373552TRLO0.1.1

05/01/2024

13:41:32

452

201

CHIX

00384373553TRLO0.1.1

05/01/2024

13:41:32

1360

201

XLON

00384373554TRLO0.1.1

05/01/2024

13:41:32

664

201

XLON

00384373555TRLO0.1.1

05/01/2024

13:48:34

452

200.5

XLON

00384375703TRLO0.1.1

05/01/2024

13:48:34

120

200.5

XLON

00384375704TRLO0.1.1

05/01/2024

13:48:34

6

200.5

XLON

00384375705TRLO0.1.1

05/01/2024

13:49:53

452

200.5

BATE

00384375969TRLO0.1.1

05/01/2024

13:49:53

326

200.5

XLON

00384375970TRLO0.1.1

05/01/2024

13:49:53

452

200.5

XLON

00384375971TRLO0.1.1

05/01/2024

13:49:53

222

200.5

XLON

00384375972TRLO0.1.1

05/01/2024

13:49:53

181

200.5

XLON

00384375973TRLO0.1.1

05/01/2024

13:49:53

1

200.5

XLON

00384375974TRLO0.1.1

05/01/2024

13:49:53

48

200.5

XLON

00384375975TRLO0.1.1

05/01/2024

14:30:10

280

201

XLON

00384384380TRLO0.1.1

05/01/2024

14:30:16

203

201

XLON

00384384416TRLO0.1.1

05/01/2024

14:30:16

203

201

XLON

00384384417TRLO0.1.1

05/01/2024

14:33:36

459

201

XLON

00384385792TRLO0.1.1

05/01/2024

14:33:36

445

201

XLON

00384385793TRLO0.1.1

05/01/2024

14:37:25

519

201.5

XLON

00384387006TRLO0.1.1

05/01/2024

14:45:35

373

200.5

XLON

00384390205TRLO0.1.1

05/01/2024

14:45:35

95

200.5

XLON

00384390206TRLO0.1.1

05/01/2024

14:45:35

254

201

AQXE

00384390207TRLO0.1.1

05/01/2024

14:45:35

3

200.5

BATE

00384390208TRLO0.1.1

05/01/2024

14:45:35

254

201

BATE

00384390209TRLO0.1.1

05/01/2024

14:45:35

1000

200.5

XLON

00384390210TRLO0.1.1

05/01/2024

14:45:35

5

200.5

TRQX

00384390211TRLO0.1.1

05/01/2024

14:45:35

1244

201

XLON

00384390213TRLO0.1.1

05/01/2024

14:45:35

324

201

XLON

00384390214TRLO0.1.1

05/01/2024

14:45:35

239

201

XLON

00384390215TRLO0.1.1

05/01/2024

14:45:35

299

201

XLON

00384390216TRLO0.1.1

05/01/2024

14:45:35

270

201

XLON

00384390217TRLO0.1.1

05/01/2024

14:45:35

270

201

XLON

00384390218TRLO0.1.1

05/01/2024

14:45:35

270

201

XLON

00384390219TRLO0.1.1

05/01/2024

14:45:35

126

201

XLON

00384390220TRLO0.1.1

05/01/2024

14:45:38

790

200.5

CHIX

00384390231TRLO0.1.1

05/01/2024

14:45:38

4

200.5

CHIX

00384390232TRLO0.1.1

05/01/2024

14:45:38

2

200.5

BATE

00384390233TRLO0.1.1

05/01/2024

14:45:40

239

201

XLON

00384390237TRLO0.1.1

05/01/2024

14:45:40

144

201

XLON

00384390239TRLO0.1.1

05/01/2024

14:45:40

239

201

XLON

00384390238TRLO0.1.1

05/01/2024

14:45:45

108

201

XLON

00384390265TRLO0.1.1

05/01/2024

14:45:45

186

201

XLON

00384390266TRLO0.1.1

05/01/2024

14:45:49

902

201

XLON

00384390287TRLO0.1.1

05/01/2024

14:45:49

1740

201

XLON

00384390286TRLO0.1.1

05/01/2024

14:45:49

386

201

XLON

00384390288TRLO0.1.1

05/01/2024

14:45:49

136

201

XLON

00384390289TRLO0.1.1

05/01/2024

14:46:10

54

201.5

CHIX

00384390449TRLO0.1.1

05/01/2024

14:46:10

212

201.5

XLON

00384390450TRLO0.1.1

05/01/2024

14:46:10

455

201.5

XLON

00384390451TRLO0.1.1

05/01/2024

14:46:15

1064

201.5

XLON

00384390497TRLO0.1.1

05/01/2024

14:46:15

608

201.5

XLON

00384390498TRLO0.1.1

05/01/2024

14:46:15

347

201.5

XLON

00384390499TRLO0.1.1

05/01/2024

14:46:15

289

201.5

XLON

00384390500TRLO0.1.1

05/01/2024

14:47:04

453

201.5

XLON

00384390922TRLO0.1.1

05/01/2024

14:47:04

326

201.5

XLON

00384390923TRLO0.1.1

05/01/2024

14:47:34

664

201

AQXE

00384391351TRLO0.1.1

05/01/2024

14:47:34

61

201

BATE

00384391352TRLO0.1.1

05/01/2024

14:47:34

34

201

CHIX

00384391353TRLO0.1.1

05/01/2024

14:47:34

1830

201

CHIX

00384391354TRLO0.1.1

05/01/2024

14:47:34

262

201

BATE

00384391355TRLO0.1.1

05/01/2024

14:47:34

3293

201

XLON

00384391356TRLO0.1.1

05/01/2024

14:47:34

364

201

TRQX

00384391357TRLO0.1.1

05/01/2024

14:47:34

4068

201

XLON

00384391358TRLO0.1.1

05/01/2024

14:47:34

4313

201

XLON

00384391359TRLO0.1.1

05/01/2024

14:47:34

420

201

XLON

00384391360TRLO0.1.1

05/01/2024

14:47:34

101

201

XLON

00384391361TRLO0.1.1

05/01/2024

14:47:34

962

201

XLON

00384391362TRLO0.1.1

05/01/2024

14:47:34

591

201

XLON

00384391363TRLO0.1.1

05/01/2024

14:47:36

322

201

BATE

00384391381TRLO0.1.1

05/01/2024

14:47:36

1219

201

XLON

00384391382TRLO0.1.1

05/01/2024

14:47:36

72

201

XLON

00384391383TRLO0.1.1

05/01/2024

14:47:52

3293

201

XLON

00384391436TRLO0.1.1

05/01/2024

14:47:52

526

201

XLON

00384391437TRLO0.1.1

05/01/2024

14:47:57

523

201

XLON

00384391447TRLO0.1.1

05/01/2024

14:53:55

9

202.5

XLON

00384393875TRLO0.1.1

05/01/2024

15:00:01

410

202.5

BATE

00384395479TRLO0.1.1

05/01/2024

15:00:01

188

202.5

BATE

00384395480TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFTLSIEIIS
12345678910
Date   Source Headline
25th Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSNotice of Results
16th Apr 202412:00 pmRNSPRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
11th Apr 202412:00 pmRNSFDA Grants PRTC's LYT-200 Fast Track Designation
9th Apr 20247:00 amRNSPRTC Launches Seaport w/ $100M; Leadership Changes
19th Mar 20247:00 amRNS$100M Tender Offer
18th Mar 20241:32 pmRNS$14B Acquisition of PRTC’s Karuna by BMS Completed
13th Mar 202411:00 amRNSFDA Grants PRTC's LYT-200 Orphan Drug Designation
6th Mar 20247:00 amRNSPDMR Notification RSU Vesting
27th Feb 202412:00 pmRNSPRTC to Present at Cowen and Leerink Conferences
27th Feb 20247:00 amRNSPRTC: Akili Positive Ph3 & Japan PMDA Submission
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20245:30 pmRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 202412:00 pmRNSPureTech to present at the JP Morgan Conference
3rd Jan 20247:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20231:31 pmRNSBMY Acquires PRTC Founded Entity Karuna for $14B
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSPRTC Year End Update & Outlook for 2024
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.